• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性磷治疗后真性红细胞增多症并发多发性骨髓瘤

Multiple myeloma on polycythemia vera following radioactive phosphorus therapy.

作者信息

West W O

出版信息

South Med J. 1976 Nov;69(11):1516-7. doi: 10.1097/00007611-197611000-00036.

DOI:10.1097/00007611-197611000-00036
PMID:1019658
Abstract

A 74-year-old white man with established polycythemia vera was treated with radioactive phosphorus after phlebotomies alone failed to control his disease. About 2 3/4 years later he died of multiple myeloma. The mutagenic effect of radioactive phosphorus may have caused or possibly accelerated preexisting myeloma. Basic nonmalignant disease deserves careful consideration before radiation or radiomimetic agents are used. One might consider a probably less mutagenic drug such as hydroxyurea in patients with polycythemia vera when phlebotomy alone does not give good control of red cell mass and thrombocytosis.

摘要

一名74岁患有真性红细胞增多症的白人男性,在仅通过放血疗法无法控制病情后,接受了放射性磷治疗。大约2又3/4年后,他死于多发性骨髓瘤。放射性磷的诱变作用可能导致了已存在的骨髓瘤,或者可能加速了其发展。在使用辐射或类辐射剂之前,对基础非恶性疾病应予以仔细考虑。当仅靠放血疗法不能很好地控制红细胞量和血小板增多时,对于真性红细胞增多症患者,可考虑使用可能诱变作用较小的药物,如羟基脲。

相似文献

1
Multiple myeloma on polycythemia vera following radioactive phosphorus therapy.放射性磷治疗后真性红细胞增多症并发多发性骨髓瘤
South Med J. 1976 Nov;69(11):1516-7. doi: 10.1097/00007611-197611000-00036.
2
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.真性红细胞增多症、原发性血小板增多症和骨髓纤维化伴髓样化生患者接受羟基脲治疗的白血病发生风险。
Am J Hematol. 1996 May;52(1):42-6. doi: 10.1002/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO;2-6.
3
[Remission incidence and adverse effects in low-dosage radioactive phosphorus therapy of polycythemia vera].[真性红细胞增多症低剂量放射性磷治疗的缓解发生率及不良反应]
Verh Dtsch Ges Inn Med. 1975;81:1128-30.
4
The use of radioactive phosphorus in the therapy of leukemia, polycythemia vera and lymphomas: a report of 10 years' experience.放射性磷在白血病、真性红细胞增多症和淋巴瘤治疗中的应用:十年经验报告
Ann Intern Med. 1958 May;48(5):956-77. doi: 10.7326/0003-4819-48-5-956.
5
[Transition of polycythemia vera into acute or chronic granulocytic leukemia in the course of treatment with radioactive P-32].[真性红细胞增多症在放射性磷-32治疗过程中转变为急性或慢性粒细胞白血病]
Pol Tyg Lek. 1975 Feb 10;30(6):233-6.
6
[Efficacious treatment of a fatal blood disease: polycythemia vera].[一种致命血液疾病——真性红细胞增多症的有效治疗方法]
Sangre (Barc). 1997 Jun;42(3):215-8.
7
[Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature].[真性红细胞增多症与多发性骨髓瘤的关联。1例新病例报告及文献复习]
Sangre (Barc). 1993 Dec;38(6):497-9.
8
[Treatment with radioactive phosphorus of patients with polycythemia vera and lymphogranulomatosis].[真性红细胞增多症和淋巴肉芽肿病患者的放射性磷治疗]
Med Radiol (Mosk). 1960 May;5:26-9.
9
The use of 32 phosphorus (32P) in the treatment of polycythemia vera.32磷(32P)在真性红细胞增多症治疗中的应用。
Nouv Rev Fr Hematol (1978). 1994 Apr;36(2):189-92.
10
Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".真性红细胞增多症患者接受³²P或化疗治疗后患白血病、癌症和骨髓纤维化的风险:682例病例的前瞻性分析。“法国真性红细胞增多症研究合作组”
Leuk Lymphoma. 1996 Sep;22 Suppl 1:111-9. doi: 10.3109/10428199609074368.

引用本文的文献

1
Polycythaemia: an unusual presentation of multiple myeloma.真性红细胞增多症:多发性骨髓瘤的一种罕见表现。
BMJ Case Rep. 2016 Sep 20;2016:bcr2016216686. doi: 10.1136/bcr-2016-216686.